Is Precigen Stock a Good Investment?

Precigen Investment Advice

  PGEN
To provide specific investment advice or recommendations on Precigen stock, we recommend investors consider the following general factors when evaluating Precigen. This will help you to make an informed decision on whether to include Precigen in one of your diversified portfolios:
  • Examine Precigen's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Precigen's leadership team and their track record. Good management can help Precigen navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Biotechnology space and any emerging trends that could impact Precigen's business and its evolving consumer preferences.
  • Compare Precigen's performance and market position to its competitors. Analyze how Precigen is positioned in terms of product offerings, innovation, and market share.
  • Check if Precigen pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Precigen's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Precigen stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Precigen is a good investment.
 
Sell
 
Buy
Strong Sell
We provide trade recommendations to complement the recent expert consensus on Precigen. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Precigen is not overpriced, please check all Precigen fundamentals, including its debt to equity, market capitalization, and the relationship between the ebitda and earnings per share . As Precigen appears to be a penny stock we also advise to check out its price to earning numbers.

Market Performance

Very WeakDetails

Volatility

RiskyDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Precigen Stock

Researching Precigen's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 64.0% of the company shares are owned by institutional investors. The book value of Precigen was at this time reported as 0.48. The company recorded a loss per share of 0.54. Precigen had not issued any dividends in recent years.
To determine if Precigen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Precigen's research are outlined below:
Precigen generated a negative expected return over the last 90 days
Precigen has some characteristics of a very speculative penny stock
Precigen has high historical volatility and very poor performance
The company reported the previous year's revenue of 6.22 M. Net Loss for the year was (95.9 M) with profit before overhead, payroll, taxes, and interest of 20.57 M.
Precigen currently holds about 115.3 M in cash with (66.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Precigen has a poor financial position based on the latest SEC disclosures
Roughly 64.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: Insiders Sold Precigen Prematurely At US1.41 With Stock Trading Higher

Precigen Quarterly Cost Of Revenue

1.01 Million

Precigen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Precigen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Precigen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Precigen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Precigen's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-14
2024-03-31-0.09-0.1-0.0111 
2023-05-10
2023-03-31-0.09-0.1-0.0111 
2023-03-06
2022-12-31-0.1-0.11-0.0110 
2023-08-09
2023-06-30-0.1-0.080.0220 
2021-08-09
2021-06-30-0.12-0.10.0216 
2022-05-09
2022-03-31-0.13-0.10.0323 
2016-11-09
2016-09-30-0.21-0.24-0.0314 
2022-08-08
2022-06-30-0.13-0.090.0430 

Know Precigen's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Precigen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Precigen backward and forwards among themselves. Precigen's institutional investor refers to the entity that pools money to purchase Precigen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Northern Trust Corp2024-09-30
M
Gmt Capital Corp2024-06-30
668.8 K
Nuveen Asset Management, Llc2024-06-30
535 K
Emfo, Llc2024-06-30
519.5 K
Tang Capital Management Llc2024-09-30
500 K
Clarivest Asset Management Llc2024-06-30
492.2 K
Bank Of New York Mellon Corp2024-06-30
421.8 K
Advisor Group Holdings, Inc.2024-06-30
408.3 K
Citadel Advisors Llc2024-09-30
383 K
Patients Capital Management Llc2024-09-30
17.9 M
Blackrock Inc2024-06-30
10.2 M
Note, although Precigen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Precigen's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 264.34 M.

Market Cap

311.29 Million

Precigen's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(1.15)(1.20)
Return On Capital Employed(0.69)(0.73)
Return On Assets(0.63)(0.67)
Return On Equity(0.81)(0.85)
Determining Precigen's profitability involves analyzing its financial statements and using various financial metrics to determine if Precigen is a good buy. For example, gross profit margin measures Precigen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Precigen's profitability and make more informed investment decisions.

Evaluate Precigen's management efficiency

Precigen has return on total asset (ROA) of (0.4232) % which means that it has lost $0.4232 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2932) %, meaning that it created substantial loss on money invested by shareholders. Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Tangible Assets is likely to drop to -1.2. In addition to that, Return On Capital Employed is likely to drop to -0.73. At this time, Precigen's Non Currrent Assets Other are very stable compared to the past year. As of the 25th of November 2024, Intangible Assets is likely to grow to about 78.7 M, while Total Assets are likely to drop about 143.5 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.48  0.51 
Tangible Book Value Per Share 0.21  0.22 
Enterprise Value Over EBITDA(3.67)(3.85)
Price Book Value Ratio 2.77  4.45 
Enterprise Value Multiple(3.67)(3.85)
Price Fair Value 2.77  4.45 
Enterprise Value327.2 M310.8 M
Precigen benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Beta
1.682

Basic technical analysis of Precigen Stock

As of the 25th of November, Precigen holds the Variance of 14.39, coefficient of variation of (1,458), and Risk Adjusted Performance of (0.04). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Precigen, as well as the relationship between them.

Precigen's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Precigen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Precigen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Precigen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Precigen's Outstanding Corporate Bonds

Precigen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Precigen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Precigen bonds can be classified according to their maturity, which is the date when Precigen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Precigen's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Precigen's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Precigen's intraday indicators

Precigen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Precigen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Precigen time-series forecasting models is one of many Precigen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Precigen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Precigen Stock media impact

Far too much social signal, news, headlines, and media speculation about Precigen that are available to investors today. That information is available publicly through Precigen media outlets and privately through word of mouth or via Precigen internal channels. However, regardless of the origin, that massive amount of Precigen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Precigen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Precigen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Precigen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Precigen alpha.

Precigen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Precigen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Precigen Corporate Management

Rob RussellVP ResourcesProfile
Mr JDChief SecretaryProfile
Donald LehrChief SecretaryProfile
Rutul ShahChief OfficerProfile
Jeffrey PerezSenior AffairsProfile
Jeffrey JDSenior AffairsProfile
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Revenue Per Share
0.018
Quarterly Revenue Growth
(0.59)
Return On Assets
(0.42)
Return On Equity
(1.29)
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Precigen's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.